Inventor
SCIAVOLINO FRANK C
US36 patents
⚠️ This page may combine multiple inventors who share the name “SCIAVOLINO FRANK C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PFIZER
20 patentsUS4565653AJan 21, 1986
Acyltripeptide immunostimulants
PFIZER101 citations94
US4382086AMay 3, 1983
9-Dihydro-11,12-ketal derivatives of erythromycin A and epi-erythromycin A
PFIZER18 citations82
US4150220AApr 17, 1979
Semi-synthetic 4"-erythromycin A derivatives
PFIZER16 citations74
US4090017AMay 16, 1978
4-Deoxy-4-substituted amino derivatives of oleandomycin
PFIZER16 citations74
US4069379AJan 17, 1978
Semi-synthetic oleandomycins
PFIZER9 citations74
US4036853AJul 19, 1977
Semi-synthetic oleandomycin derivatives-C8 modifications
PFIZER7 citations74
US4129578ADec 12, 1978
Polycyclic ether antibiotic
PFIZER12 citations73
US4382085AMay 3, 1983
4"-Epi erythromycin A and derivatives thereof as useful antibacterial agents
PFIZER15 citations71
US4283527AAug 11, 1981
Erythromycylamine 11,12-carbonate and derivatives thereof
PFIZER5 citations63
US4180654ADec 25, 1979
4"-Deoxy-4"-acylamido derivatives of oleandomycin, erythromycin and erythromycin carbonate
PFIZER4 citations63
US4125705ANov 14, 1978
Semi-synthetic 4-amino-oleandomycin derivatives
PFIZER3 citations63
US4110531AAug 29, 1978
Semi-synthetic oleandomycin derivatives - C8 modifications
PFIZER1 citations63
US4110530AAug 29, 1978
Semi-synthetic oleandomycin derivatives - C8 modifications
PFIZER1 citations63
US4013789AMar 22, 1977
Mixture of antibiotics produced by new species of micromonospora
PFIZER4 citations62
US4189590AFeb 19, 1980
Semi-synthetic oleandomycin derivatives--C8 modifications
PFIZER0 citations52
US4188479AFeb 12, 1980
Semi-synthetic oleandomycin derivatives-C8 modifications
PFIZER0 citations52
US4182857AJan 8, 1980
Semi-synthetic oleandomycin derivatives - C8 modifications
PFIZER0 citations52
US4182858AJan 8, 1980
Semi-synthetic oleandomycin derivatives - C8 modifications
PFIZER0 citations52
US4178436ADec 11, 1979
Semi-synthetic oleandomycin derivatives-C8 modifications
PFIZER1 citations52
US4062944ADec 13, 1977
Mixture of antibiotics produced by new species of micromonospora
PFIZER0 citations52
THETIS PHARMACEUTICALS LLC
16 patentsUS8933124B2Jan 13, 2015
Tri-salt form of metformin
THETIS PHARMACEUTICALS LLC8 citations84
US8765811B2Jul 1, 2014
Tri-salt form of metformin
THETIS PHARMACEUTICALS LLC11 citations84
US9242008B2Jan 26, 2016
Mineral amino-acid complexes of fatty acids
THETIS PHARMACEUTICALS LLC8 citations82
US9505709B2Nov 29, 2016
Compositions and methods relating to ionic salts of peptides
THETIS PHARMACEUTICALS LLC6 citations72
US10420843B2Sep 24, 2019
Compositions and methods relating to salts of specialized pro-resolving mediators
THETIS PHARMACEUTICALS LLC3 citations71
US10130719B2Nov 20, 2018
Compositions and methods relating to salts of specialized pro-resolving mediators
THETIS PHARMACEUTICALS LLC3 citations71
US9999626B2Jun 19, 2018
Mineral amino-acid complexes of active agents
THETIS PHARMACEUTICALS LLC4 citations71
US9216951B2Dec 22, 2015
Lipid-lowering antidiabetic agent
THETIS PHARMACEUTICALS LLC1 citations63
US9012507B2Apr 21, 2015
Lipid-lowering antidiabetic agent
THETIS PHARMACEUTICALS LLC1 citations63
US8901107B2Dec 2, 2014
Lipid-lowering antidiabetic agent
THETIS PHARMACEUTICALS LLC2 citations63
US11925688B2Mar 12, 2024
Compositions and methods relating to salts of specialized pro-resolving mediators
THETIS PHARMACEUTICALS LLC0 citations60
US11191840B2Dec 7, 2021
Compositions and methods relating to salts of specialized pro-resolving mediators
THETIS PHARMACEUTICALS LLC0 citations60
US11135298B2Oct 5, 2021
Compositions and methods relating to salts of specialized pro-resolving mediators
THETIS PHARMACEUTICALS LLC0 citations60
US12564644B2Mar 3, 2026
Cyclodextrin complexes of specialized proresolving mediators
THETIS PHARMACEUTICALS LLC0 citations55
US9382187B2Jul 5, 2016
Tri-salt form of metformin
THETIS PHARMACEUTICALS LLC1 citations52
US11986512B2May 21, 2024
Compositions and methods for cancer therapy
THETIS PHARMACEUTICALS LLC0 citations44